Yahoo Web Search

Search results

1. seekingalpha.com › symbol › VRNAVerona Pharma plc (VRNA) Stock Price, Quote, News & Analysis

   seekingalpha.com › symbol › VRNA

   • Cached

   4 days ago · 11.83 23.81. Day Range. 15.51 16.00. EPS (FWD) -0.60. PE. - Div Rate (TTM) - Yield (TTM) - Market Cap. $1.27B. Volume. 359,330. Prev. Close. $15.72. VRNA Analysis. Verona Pharma: A Few Points...

2. Verona Pharma plc

   NasdaqGM: VRNA

   14.95

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.74 (-4.72%)

   At close: Mon. May 6, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	15.69
     High	15.69
     Low	14.72

   • Mkt Cap	1.16B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	15.69
     52 Wk. Low	11.83
     52 Wk. High	23.81

   More about VRNA

   Related stocks

   • IMRN
     Immuron Limited
     IMRN
     2.5250
     -0.20%
   • PTGX
     Protagonist Therapeutics, Inc.
     PTGX
     26.06
     -0.11%
   • RYTM
     Rhythm Pharmaceuticals, Inc.
     RYTM
     43.88
     +0.27%
   • AKRO
     Akero Therapeutics, Inc.
     AKRO
     22.11
     +12.46%
   • MIST
     Milestone Pharmaceuticals Inc.
     MIST
     1.7400
     +3.57%

   More on Yahoo Finance

3. www.globenewswire.com › news-release › 2023/06/28Verona Pharma Announces Publication of Phase 3 ENHANCE Data

   www.globenewswire.com › news-release › 2023/06/28

   • Cached

   Jun 28, 2023 · LONDON and RALEIGH, N.C., June 28, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the American Journal of Respiratory and Critical...

4. finance.yahoo.com › news › verona-pharma-reports-fourthVerona Pharma Reports Fourth Quarter and Full Year 2023 ...

   finance.yahoo.com › news › verona-pharma-reports-fourth

   • Cached

   Feb 29, 2024 · LONDON and RALEIGH, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) ("Verona Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on...

5. markets.businessinsider.com › news › stocksVerona Pharma to Present Additional Analyses of Positive ...

   markets.businessinsider.com › news › stocks

   • Cached

   5 days ago · Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs.

6. veronapharma.gcs-web.com › news-releases › news-releaseVerona Pharma Reports First Quarter 2023 Financial Results ...

   veronapharma.gcs-web.com › news-releases › news-release

   • Cached

   Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update. NDA submission on schedule for Q2 2023. 12 abstracts and one symposium expanding on successful Phase 3 ENHANCE data to be presented at American Thoracic Society 2023. Strong balance sheet to support commercial launch preparations.

7. markets.businessinsider.com › news › stocksVerona Pharma's Promising COPD Treatment Puts It in GSK's ...

   markets.businessinsider.com › news › stocks

   • Cached

   Dec 29, 2023 · News for Verona Pharma. Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves. Benzinga. Dec. 29, 2023, 01:24 PM.

8. www.globenewswire.com › news-release › 2022/06/09Verona Pharma Completes Enrollment in Phase 3 ENHANCE-1

   www.globenewswire.com › news-release › 2022/06/09

   • Cached

   Jun 9, 2022 · Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet...